168 HR granisetron 0.129 MG/HR Transdermal System [Sancuso]
RxNorm concept 825005, branded drug (sbd). Prescribable name: Sancuso 3.1 MG/Day 7 Day Transdermal System.
- RxCUI
- 825005
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/825005 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
168 HR Sancuso 0.129 MG/HR Transdermal System; Sancuso 3.1 MG/Day 7 Day Transdermal System; Sancuso 3.1 MG/Day Weekly Transdermal Patch
Related concepts
- granisetron 0.129 MG/HR (SCDC, consists of)
- granisetron 0.129 MG/HR [Sancuso] (SBDC, consists of)
- Transdermal System (DF, has dose form)
- Sancuso (BN, has ingredient)
- 168 HR granisetron 0.129 MG/HR Transdermal System (SCD, tradename of)
Linked data
NDCs
- 42747072601
- 66220063731
- 66220063772
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 825005 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/825005 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 825005. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.